Search Results

You searched for : foodanddrugadministration  

Hoth Therapeutics Announces Production of HT-001 for Cancer Treatment

Hoth Therapeutics, Inc. a biopharmaceutical company, today announced that it has signed a production agreement for both GLP and GMP materials associated with HT-001 ...
Jan 01

OraSure Technologies Provides Update on Its Emergency Use Authorization Application for Its Lab-based Oral Fluid SARS-CoV-2 Antibody Test

The OraSure SARS-CoV-2 Antibody ELISA is intended for the qualitative detection of total antibodies to SARS-CoV-2 in human oral fluid specimens ...
Dec 22

APhA Statement Following Emergency Use Authorization of the Moderna COVID-19 Vaccine

Statement from Scott J. Knoer, MS, PharmD, FASHP, executive vice president and CEO of the American Pharmacists Association, upon the Food and Drug Administration's (...
Dec 19

Coronavirus (COVID-19) Update: FDA Issues New Authorization for the BinaxNOW COVID-19 Ag Card Home Test

Today, the U.S. Food and Drug Administration issued a new emergency use authorization (EUA) for the BinaxNOW COVID-19 Ag Card Home Test which ...
Dec 17

FDA Approves Y-mAbs’ DANYELZA® (naxitamab-gqgk) for the Treatment of Neuroblastoma

Y-mAbs Therapeutics today announced that the U.S. Food and Drug Administration (“FDA”) has approved DANYELZA (naxitamab-gqgk) for the Treatment of Neuroblastoma....
Nov 26

FDA grants priority review for avalglucosidase alfa, a potential new therapy for Pompe disease.

The U.S. Food and Drug Administration (FDA) has accepted for priority review the Biologics License Application (BLA) for avalglucosidase alfa for long-term enzyme ...
Nov 20

North America Allergy Immunotherapies Market to Forecast to 2027- COVID-19 Impact and Analysis- By Treatment, Allergy type, Distribution Channel and Geography

North America Allergy Immunotherapies Market to Forecast to 2027- COVID-19 Impact and Analysis- By Treatment, Allergy type, Distribution Channel and Geography...
Oct 28

Gilead's remdesivir gets U.S. FDA approval for hospitalized COVID-19 patients

The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalized with COVID-19...
Oct 23

8 Matching result(s) found!

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026